Research Progress on the Mechanism of Action of Hesperetin in Cerebral Ischemia: a Narrative Review

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2022 Aug 15

PMID 35965833

Authors

Qingchun Mu

Yufei Zhang

Qian Cheng

Hanning Huang

Chunming Huang

Longguang Tang

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Ischemic cerebrovascular disease is one of the main diseases threatening human health and survival and is a commonly occurring disease in neurology. Due to its high disability rate, ischemic cerebrovascular disease is one of the most important diseases to be prevented and treated at present. The risk factors of cerebral ischemia include atherosclerosis, hypertension, hyperlipidemia, and blood viscosity caused by thrombocytosis. After cerebral ischemia, cerebral ischemia-reperfusion injury may be induced by oxidative stress (OS), inflammatory reaction, nitric oxide damage, apoptosis, excitatory amino acid toxicity, calcium (Ca) overload, and other mechanisms. Hesperidin is a flavanone compound and is a key component in citrus plants. It is a kind of traditional Chinese medicine extract with high levels of Pericarpium, shell, fruit, and green peel. In recent years, Hesperidin has received great attention, compelling evidence has indicated Hesperidin plays a beneficial role in cerebral ischemia.

Methods: We conducted a literature search for published manuscripts hesperidin in ischemia/reperfusion up to December 2021 in common English databases (i.e., PubMed, EMBASE, Web of Science, SpringerLink, Wiley, Cochrane Library) and Chinese databases [Chinese BioMedical Literature Service System (CBM), WANFANG database, China Knowledge Resource Integrated Database (CNKI)].

Key Content And Findings: In this article, we reviewed the mechanisms of action of hesperidin in the treatment of cerebral ischemia, including antioxidant stress, anti-inflammatory reaction, anti-atherosclerosis, anti-thrombosis, anti-apoptosis, and nitric oxide regulation.

Conclusions: In this narrative review, Hesperidin exhibits antioxidant stress, anti-platelet aggregation, vasodilation, anti-atherosclerotic, anti-inflammatory, anti-apoptotic, hypolipidemic, anti-tumor, cardiovascular protection, and nitric oxide-release regulatory properties Such a comprehension of the recent progress of hesperidin will help identify biomarkers for diagnosis and therapeutic targets to cerebral ischemia.

Citing Articles

Rapid-Test Kit for Cardiac Troponin I: A Reliable Enzyme-Linked-Immuno-Substrate-Assay-Based Biosensor for Daily-Use Naked-Eye Detection and Pharmacokinetic Studies for Myocardial Infarction in Cardiovascular Disease.

Hsieh Y, Lin K ACS Pharmacol Transl Sci. 2024; 7(8):2369-2378.

PMID: 39144556 PMC: 11321260. DOI: 10.1021/acsptsci.4c00218.

Investigation of the molecular mechanism of Roxb. in treating hypertension based on proteomics and bioinformatics.

Yang X, Qian H, Yang C, Zhang Z Front Pharmacol. 2024; 15:1360829.

PMID: 38783958 PMC: 11112092. DOI: 10.3389/fphar.2024.1360829.

Neurotrophic Natural Products.

Fukuyama Y, Kubo M, Harada K Prog Chem Org Nat Prod. 2024; 123:1-473.

PMID: 38340248 DOI: 10.1007/978-3-031-42422-9_1.

The Antidiabetic Mechanisms of Hesperidin: Hesperidin Nanocarriers as Promising Therapeutic Options for Diabetes.

Kaviani F, Baratpour I, Ghasemi S Curr Mol Med. 2023; 24(12):1483-1493.

PMID: 37986269 DOI: 10.2174/0115665240268940231113044317.

Dapagliflozin/Hesperidin Combination Mitigates Lipopolysaccharide-Induced Alzheimer's Disease in Rats.

Abd Elmaaboud M, Estfanous R, Atef A, Kabel A, Alnemari K, Naguib T Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895841 PMC: 10609711. DOI: 10.3390/ph16101370.

References

Okada Y, Copeland B, Mori E, Tung M, Thomas W, Del Zoppo G . P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke. 1994; 25(1):202-11. DOI: 10.1161/01.str.25.1.202. View

Hankey G . Thrombolysis for acute ischaemic stroke. J Clin Neurosci. 2001; 8(2):103-5. DOI: 10.1054/jocn.2000.0838. View

Zhao L, Wang R, Song B, Tan S, Gao Y, Fang H . Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke. Int J Stroke. 2015; 10(5):752-8. DOI: 10.1111/ijs.12471. View

Liu H, Dong Y, Gao Y, Zhao L, Cai C, Qi D . Hesperetin suppresses RANKL-induced osteoclastogenesis and ameliorates lipopolysaccharide-induced bone loss. J Cell Physiol. 2018; 234(7):11009-11022. DOI: 10.1002/jcp.27924. View

Zhao Z . Postconditioning in reperfusion injury: a status report. Cardiovasc Drugs Ther. 2010; 24(3):265-79. DOI: 10.1007/s10557-010-6240-1. View

de Oliveira J, Santos C, Fernandes E . Therapeutic potential of hesperidin and its aglycone hesperetin: Cell cycle regulation and apoptosis induction in cancer models. Phytomedicine. 2019; 73:152887. DOI: 10.1016/j.phymed.2019.152887. View

Sang Eun H, Seong Min K, Ho Jeong L, Vetrivel P, Gowda Saralamma V, Jeong Doo H . Scutellarein Induces Fas-Mediated Extrinsic Apoptosis and G2/M Cell Cycle Arrest in Hep3B Hepatocellular Carcinoma Cells. Nutrients. 2019; 11(2). PMC: 6412708. DOI: 10.3390/nu11020263. View

Velusamy P, Mohan T, Ravi D, Kishore Kumar S, Srinivasan A, Chakrapani L . Targeting the Nrf2/ARE Signalling Pathway to Mitigate Isoproterenol-Induced Cardiac Hypertrophy: Plausible Role of Hesperetin in Redox Homeostasis. Oxid Med Cell Longev. 2020; 2020:9568278. PMC: 7482027. DOI: 10.1155/2020/9568278. View

Chen X, Li X, Chen Y, Zhu S, Li H, Chen S . Hesperetin derivative attenuates CCl-induced hepatic fibrosis and inflammation by Gli-1-dependent mechanisms. Int Immunopharmacol. 2019; 76:105838. DOI: 10.1016/j.intimp.2019.105838. View

10.

Turley K, Toledo-Pereyra L, Kothari R . Molecular mechanisms in the pathogenesis and treatment of acute ischemic stroke. J Invest Surg. 2005; 18(4):207-18. DOI: 10.1080/08941930591004449. View

11.

Wei L, Deng W, Cheng Z, Guo H, Wang S, Zhang X . Effects of hesperetin on platelet-derived growth factor-BB-induced pulmonary artery smooth muscle cell proliferation. Mol Med Rep. 2015; 13(1):955-60. DOI: 10.3892/mmr.2015.4625. View

12.

Parhiz H, Roohbakhsh A, Soltani F, Rezaee R, Iranshahi M . Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res. 2014; 29(3):323-31. DOI: 10.1002/ptr.5256. View

13.

Actis-Goretta L, Dew T, Leveques A, Pereira-Caro G, Rein M, Teml A . Gastrointestinal absorption and metabolism of hesperetin-7-O-rutinoside and hesperetin-7-O-glucoside in healthy humans. Mol Nutr Food Res. 2015; 59(9):1651-62. DOI: 10.1002/mnfr.201500202. View

14.

Choi E . Antioxidative effects of hesperetin against 7,12-dimethylbenz(a)anthracene-induced oxidative stress in mice. Life Sci. 2008; 82(21-22):1059-64. DOI: 10.1016/j.lfs.2008.03.002. View

15.

Khan A, Ikram M, Hahm J, Kim M . Antioxidant and Anti-Inflammatory Effects of Flavonoid Hesperetin: Special Focus on Neurological Disorders. Antioxidants (Basel). 2020; 9(7). PMC: 7402130. DOI: 10.3390/antiox9070609. View

16.

Roohbakhsh A, Parhiz H, Soltani F, Rezaee R, Iranshahi M . Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci. 2015; 124:64-74. DOI: 10.1016/j.lfs.2014.12.030. View

17.

Siesjo B, Katsura K, Zhao Q, Folbergrova J, Pahlmark K, Siesjo P . Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis. J Neurotrauma. 1995; 12(5):943-56. DOI: 10.1089/neu.1995.12.943. View

18.

Ameer B, WEINTRAUB R, Johnson J, Yost R, Rouseff R . Flavanone absorption after naringin, hesperidin, and citrus administration. Clin Pharmacol Ther. 1996; 60(1):34-40. DOI: 10.1016/S0009-9236(96)90164-2. View

19.

Yang G, Wang Y, Zeng Y, Gao G, Liang X, Zhou M . Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2013; 381(9882):1987-2015. PMC: 7159289. DOI: 10.1016/S0140-6736(13)61097-1. View

20.

Wang D, Gao D, Huang Y, Xu W, Xia Z . Preparation of restricted access molecularly imprinted polymers based fiber for selective solid-phase microextraction of hesperetin and its metabolites in vivo. Talanta. 2019; 202:392-401. DOI: 10.1016/j.talanta.2019.05.016. View